why do people gain weight after stopping semaglutide How To Not Ozempic​? weight gain after semaglutide Rebound

(If, however, you lose weight but not body fat, your hormone levels may not change)

Wegovy is a glucagon-like peptide-1 receptor agonist (also known as GLP-1 receptor agonist or GLP-1 RA), which bagged US Food and Drug Administrations approval as a treatment for obesity in June 2021

The studies included analyzes of clinical records and real-world databases tracking patients taking Novo Nordisks NOVOb.CO Wegovy or Ozempic, Eli Lillys LLY.N Zepbound or Mounjaro, or older GLP-1 treatments

Some patients find their levothyroxine dose requires adjustment downward as they lose weight, though this is not universal and must be determined through blood test monitoring

Retatrutide + Cagrilintide: combination format for multi-pathway metabolic studies

JAMA , 329 (10), 957-959